Recap Of Thursday's Biotech Catalysts - End Of the Day Summary

By: via Benzinga
Pfizer (NYSE: PFE) announced positive top-line data from the Phase 3 clinical trialRENOIR investigating its bivalent RSV ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.